Evaluation of ALT-2074 in Subjects With Type-2 Diabetes, Haptoglobin Type 2-2 Genotype and Coronary Artery Disease
Clinical trial NCT00491543 · COMPLETED
Trial details
- NCT number
- NCT00491543
- Sponsor
- Synvista Therapeutics, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.